Skip to main content

Acyclovir

FDA recalls

6 rows

Date	Company and reason	Class
Apr 20, 2021	Heritage Pharmaceuticals Inc Labeling: Incorrect or Missing Lot and/or Exp Date	Class III · Terminated
Feb 17, 2021	Zydus Pharmaceuticals (USA) Inc Crystallization: customer complaints for crystallization in finished product.	Class I · Terminated
Apr 24, 2019	Zydus Pharmaceuticals USA Inc Labeling; Label Mix-up; report received of one bottle labeled as Acyclovir Tablets USP 400 mg actually contained Carvedilol Tablets 6.25 mg	Class II · Terminated
Feb 8, 2018	Apace Ky LLC Presence of Foreign Tablet/Capsule; cartons labeled to contain Acyclovir tablets may contain Torsemide tablets in some of the blister cavities.	Class II · Terminated
Apr 26, 2017	Hetero USA Inc Presence of Foreign Substance: human hair melded into tablet.	Class III · Terminated
Jul 16, 2013	Apotex Inc. Presence of Particulate Matter: Product from lot KF2199, may contain tablets with pieces of nitrile rubber glove embedded within the tablets.	Class II · Terminated

← Back to Acyclovir

Sources: CMS Medicare Part D Prescribers 2024; CMS Open Payments 2025 (general payments; a payment is not evidence of wrongdoing); FDA enforcement reports (openFDA).